Cite

HARVARD Citation

    Kounatidou, E. et al. (2019). A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. Nucleic acids research. 47 (11), pp. 5634-5647. [Online]. 
  
Back to record